コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 icin and paromomycin alone for ulcerative L. major disease.
2 substantially decrease the incidence of this major disease.
3 of homocysteine are associated with several major diseases.
4 s an important therapeutic target in several major diseases.
5 reducing mortality and disability from most major diseases.
6 an counter to declining mortality from other major diseases.
7 f three medications that are used to prevent major diseases.
12 tes pharmacological potential in the cure of major diseases and numerous biotechnological application
13 he potential for prevention and treatment of major diseases and potentially therapeutic regeneration
14 ive against strains that are associated with major diseases and resistant to multiple drugs could be
15 man genetic factors, the risks of developing major diseases and the molecular basis of drug efficacy
17 an initiative to resolve disputed origins of major diseases, and a global early warning system to mon
18 ative capabilities of complement, highlights major disease areas with known complement contribution,
20 ete revascularization with one graft to each major diseased artery system; 2) functional complete rev
21 rized by a FitzGibbon A-quality graft to the major diseased artery, and there were no new postanastom
22 erstanding and characterization of these two major diseases as well as their associated viruses and w
23 f its pathogenesis through identification of major disease associated pathways-knowledge that has the
24 ar cells from individuals homozygous for the major disease-associated L1007fsinsC NOD2 mutation respo
25 ses of T cell clones that are specific for a major disease-associated peptide to antigen-pulsed intac
26 TAR DNA binding protein 43 (TDP-43) is a major disease-associated protein involved in the pathoge
27 d with oncogenic papilloma viruses, remain a major disease burden in the absence of effective impleme
28 ion of the aero-digestive tract represents a major disease burden of the elderly, and despite recent
30 ive protein (CRP) concentration with risk of major diseases can best be assessed by long-term prospec
32 oint prevalence figures for each of the five major disease categories are comparable with those from
36 lalanine residue in Yor1p, equivalent to the major disease-causing mutation in CFTR, causes ER retent
38 equence of six strains representing the five major disease-causing serotypes of Streptococcus agalact
42 l of 67272 US female nurses who were free of major disease completed detailed questionnaires on diet
46 ly known to be related to mortality and four major diseases contributing to mortality, to develop a l
48 survival motor neuron) is thought to be the major disease determining gene since it is missing in th
49 whether T cell responses to neoepitopes are major disease drivers that could impact prediction, prev
50 ations deal with RNA viruses associated with major disease emergence events, such as HIV-1, influenza
52 garding the effect of periodontal therapy on major disease endpoints such as tooth loss, edentulism,
54 of the peripheral nervous system and is the major disease gene for the rare congenital breathing dis
57 phylum of intracellular parasites that cause major diseases in humans and animals and are evolutionar
58 ure on the development of the microbiome and major diseases including allergy and infection in large
60 are associated with reduced risk of several major diseases, including neurodegenerative disorders.
61 is of granulomas is linked to progression of major diseases, including tuberculosis and atheroscleros
64 rone, and plasma renin activity, are the two major diseases linked so far to mutations in a Kir chann
67 macological therapies for RP must target the major disease mechanism and contend with overlap, if it
76 Recent research suggests that several of the major diseases of later life, including coronary heart d
77 proteins, but whether fungi, which cause the major diseases of most crop species, also require differ
81 range of preclinical strategies for tackling major diseases of the nervous system, the clinical limit
84 ough HCM may progress along 1 or more of its major disease pathways (i.e., arrhythmic sudden death ri
91 TAR DNA-binding protein 43 (TDP-43) is a major disease protein in amyotrophic lateral sclerosis (
94 ed to assess current methods of managing the major diseases related to hepatic dysfunction in pregnan
95 and controls) FDG-PET dataset extracted two major disease-related metabolic components: (a) a nonspe
97 and leucine-rich-repeat proteins (NLRs), the major disease-resistance gene families, has been unexplo
98 ed at diagnosis, the reliable achievement of major disease responses makes extensive BM testing and M
99 re young adults (median age, 22 years) whose major disease risk was residence in population-dense cen
100 enting infection of the oviduct and thus the major disease sequelae associated with chlamydial infect
105 st has broad application to the treatment of major diseases such as diabetes and a wide range of othe
106 ans have provided unambiguous evidence for a major disease susceptibility locus on chromosome 6p21 (P
107 acterial blight of rice (Oryza sativa L.), a major disease that constrains production of this staple
108 g these drugs that demonstrate reductions in major diseases that treatment of hypertension is intende
109 rdered proteins are closely linked with many major diseases, their binding mechanisms with small mole
112 tivation of CO(2)-detecting neurons in three major disease-transmitting mosquitoes: Anopheles gambiae
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。